Press coverage about Aetna (NYSE:AET) has been trending somewhat positive this week, Accern reports. Accern identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aetna earned a media sentiment score of 0.01 on Accern’s scale. Accern also gave media coverage about the company an impact score of 44.5177418008586 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- California’s regulators to investigate Aetna’s medical coverage decisions – The CT Mirror (ctmirror.org)
- Augmenix, Inc. Announces Aetna’s Positive Coverage Decision for … – Business Wire (press release) (businesswire.com)
- Investigation In Aetna’s Approval Process Expands Into More States (khn.org)
- Aetna will cover Augmenix’s SpaceOAR Hydrogel procedure for men with prostate cancer (dotmed.com)
- Yahoo Finance Live: Midday Movers – Feb 14th, 2018 (finance.yahoo.com)
A number of brokerages recently commented on AET. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Jefferies Group reissued a “hold” rating and issued a $205.00 price objective on shares of Aetna in a research note on Wednesday, January 31st. Credit Suisse Group boosted their price objective on shares of Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Citigroup downgraded shares of Aetna from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $187.89 to $212.00 in a research note on Wednesday, January 31st. Finally, Cowen reissued a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Ten investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna has a consensus rating of “Buy” and an average target price of $185.94.
Shares of Aetna (NYSE AET) traded up $1.38 during mid-day trading on Friday, hitting $178.51. The stock had a trading volume of 2,140,000 shares, compared to its average volume of 2,900,000. The firm has a market capitalization of $58,360.00, a P/E ratio of 29.51, a PEG ratio of 1.45 and a beta of 0.60. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 1.68. Aetna has a 1-year low of $124.83 and a 1-year high of $194.40.
Aetna (NYSE:AET) last released its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The firm had revenue of $14.74 billion for the quarter, compared to the consensus estimate of $14.79 billion. During the same period in the prior year, the firm earned $0.08 EPS. The firm’s revenue was down 6.2% on a year-over-year basis. sell-side analysts forecast that Aetna will post 10.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.12%. The ex-dividend date was Wednesday, January 10th. Aetna’s payout ratio is 33.06%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.